Abuse-resistant OxyContin will be only version available

LOS ANGELES—Three years after it approved a version of the opioid analgesic OxyContin designed to discourage the painkiller’s abuse, the Food and Drug Administration has effectively barred the original form of the drug from ever reaching the legal U.S. market. The agency says it will approve no new applications from generic drug manufacturers to produce cheaper versions of OxyContin in its original form.

OxyContin has been one of the nation’s most abused prescription painkillers, in part because as those addicted to the potent drug built up tolerance for it, they could easily ground it up or dissolve it in water, making the potent extended-release drug easy to snort or inject for a faster, more intense high.

But in April of 2010, the FDA approved a reformulated version of the drug that was resistant to crushing, breaking, chewing or dissolving in water. The newer version is virtually unbreakable, and when dissolved in water, turns into a jelly-like mass.

The reformulated version was produced by the pharmaceutical maker Purdue Pharma, which originally brought the medication to the U.S. market in 1995. But in approving Purdue’s reformulated version in 2010, the FDA simply called it “a step in the right direction.” The agency withheld judgment on whether the new OxyContin constituted enough of an innovation to render the original version of the drug unmarketable.

As Purdue Pharma’s exclusive patent rights to produce OxyContin in its original form approached its expiration date this year, generic pharmaceutical companies began eyeing the profitable prospect of seeking the FDA’s approval to produce a low-cost version of the original OxyContin.

With Tuesday’s announcement by the FDA, that won’t happen, and Purdue Pharmaceuticals will have several more years of exclusive patent rights over its abuse-resistant formulation of OxyContin. That will likely keep high the cost of the prescription” pain medication—now sold at retail pharmacies at between $5 and $8 per pill.

That decision came after Purdue Pharma presented the FDA with laboratory and real-world studies of the reformulated OxyContin’s abuse potential. “Purdue recognizes that abuse of prescription opioid analgesics is a persistent and significant public health problem,” the company said in a statement released Tuesday. The company said it would continue to study the problem of OxyContin abuse and report its findings to the FDA.

“While both original and reformulated OxyContin are subject to abuse and misuse, the FDA has determined that reformulated OxyContin can be expected to make abuse by injection difficult and expected to reduce abuse by snorting compared to original OxyContin,” said Dr. Douglas Throckmorton, deputy director for drug regulation in the FDA’s Center for Drug Evaluation and Research.

OxyContin’s reformulation has had a dark side: in a July 2012 letter to The New England Journal of Medicine, a group of researchers revealed that after OxyContin’s reformulation, droves of people addicted to the painkiller but thwarted by the new formulation were turning to a more dangerous drug—heroin—a development likely to result in an uptick of overdoses and deaths.

More in Local News

Treatment center in north Everett could open in 2020

The 32-bed facility on 10th Street would serve people with addiction and mental illness.

NOPEYEP, YEPNOPE: We love our personalized license plates

Street Smarts asked you to send in vanity plate finds, and readers did not disappoint.

Bill Short, 74, and his sister Pat Veale, 73, attended the old Emander School, which was near what’s now I-5 and 128th Street in south Everett. (Dan Bates / The Herald)
Woman wants to commemorate a neighborhood long gone

Pat Veale and her siblings grew up in the Emander area of south Everett.

Somers sees Paine Field as focal point of a thriving county

In an annual speech, he also acknowledged challenges such as opioid addiction, crime and homelessness.

Man revived from opioid overdose at county jail

He was taken to Providence Regional Medical Center then returned to the jail a few hours later.

Man arrested after robbery reported at Lynnwood Walgreens

He matched the description of a suspect in an earlier robbery reported about three miles away.

Bomb threat clears lobby at the Snohomish County Jail

Officers shut down Oakes Avenue between Wall Street and Pacific Avenue in downtown Everett.

Slide prompts closure of Whitehorse trail east of Arlington

More than two miles of the route will be closed indefinitely “due to significant earth movement.”

Police seek man after stabbing and robbery south of Everett

A convenience store clerk was slashed by a knife-wielding man at 8 a.m. Thursday morning.

Most Read